Organic compounds -- part of the class 532-570 series – Organic compounds – Fatty compounds having an acid moiety which contains the...
Reexamination Certificate
2006-02-21
2006-02-21
Carr, Deborah D. (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Fatty compounds having an acid moiety which contains the...
C554S229000, C426S601000
Reexamination Certificate
active
07002030
ABSTRACT:
The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble β-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the β-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.
REFERENCES:
patent: 1413102 (1922-08-01), Jandacek
patent: 2422317 (1947-08-01), Stock
patent: 3004043 (1961-10-01), Stern
patent: 3600188 (1971-08-01), Mattson et al.
patent: 3751569 (1973-08-01), Erickson
patent: 3852311 (1974-12-01), Nicholas et al.
patent: 3954976 (1976-05-01), Mattson et al.
patent: 4005196 (1977-01-01), Jandacek et al.
patent: 4034083 (1977-07-01), Mattson
patent: 4160850 (1979-07-01), Hallstrom et al.
patent: 5244887 (1993-09-01), Straub
patent: 5270041 (1993-12-01), Eugster et al.
patent: 5502045 (1996-03-01), Miettinen et al.
patent: 5958913 (1999-09-01), Miettenen et al.
patent: 6174560 (2001-01-01), Miettenen et al.
patent: 6383514 (2002-05-01), Weitkemper et al.
patent: 567202 (1958-12-01), None
patent: 2035069 (1971-01-01), None
patent: 2248921 (1974-04-01), None
patent: 0195311 (1986-09-01), None
patent: 0 203 277 (1986-12-01), None
patent: 0289636 (1988-11-01), None
patent: 0 898 896 (1999-03-01), None
patent: 0 911 385 (1999-04-01), None
patent: 1405346 (1973-09-01), None
patent: 44-4974 (1944-02-01), None
patent: WO 92/19640 (1992-11-01), None
patent: WO 96/38047 (1996-12-01), None
patent: WO 97/42830 (1997-11-01), None
patent: WO 98/06405 (1998-02-01), None
patent: 967616 (1996-09-01), None
European Journal of Clinical Investigation,vol. 10, pp. 27-35, (1980), T. Miettinen “Phytosterolaemia, Xanthomalosis and Premature Atherosclerotic Arterial Disease: A Case with High Plant Sterol Absorption, Impaired Sterol Elimination and Low Cholesterol Synthesis”.
Scand. J. Gastroenterol,vol. 23., pp. 967-972, (1988), K. Nikkilä, et al. “Serum Cholesterol Precursors, Cholestanol, and Plant Sterols in Primary Billiary Cirrhosis”.
Z. Klin. Chem. Biochem.,vol. 9, pp. 47-52, (1971), T. Miettinen, et al. “Bile Salts, Sterols, Sterol Esters, Glycerides and Fatty Acids in Micellar and Oil Phases of Intestinal Contents During Fat Digestion in Man”.
Journal of Lipid Research,vol. 20, pp. 646-653, (1979), A. Hassan, et al. “Intestinal Absorption and Lymphatic Transport of Cholesterol and β-Sitostanol in the Rat”.
Journal of Organic Chemistry,vol. 25, pp. 1209-1219, (1960), A. Kuksis, et al. “Preparation and Certain Physical Properties of Some Plant Steryl Esters”.
Synthetic Communications,vol. 16, pp. 1423-1430, (1986), M. Saroja, et al. “A Convenient Method of Esterification of Fatty Acids, Preparation of Alkyl Esters, Sterol Esters, Wax Esters and Triacylglycerols”.
Lipids,vol. 12, pp. 242-244, (1977), A. Prabhudesal “A Simple Method for the Preparation of Cholesterol Esters”.
Chemistry and Physics of Lipids.vol. 15, pp. 216-221, (1975), B. Lentz, et al. “A Simple Method for the Synthesis of Cholesterol Esters in High Yield”.
Organic Preparations and Procedures,vol. 1(2), pp. 107-109, (1969), R. Augustine, et al. “The Palladium Catalyzed Hydrogenation of Cholesterol”.
Journal of American Oil Chemists' Society,vol. 55, pp. 796-805, (1978), B. Sreenivasan “Interestenfication of Fats”.
Journal of American Oil Chemists' Society,vol. 60, pp. 815-818, (1983), Y. Lo, et al. “Physical and Chemical Properties of Randomly Interesterified Blends of Soybean Oil and Tallow for Use as Margarine Oils”.
Circulation,vol. 7, pp. 702-706, (May 1953), O. Pollak “Reduction of Blood Cholesterol in Man”.
Pric. Soc. Exp. Biol Med.,vol. 78, pp. 143-147 (1951), D. Peterson “Effect of Soybean Sterols in the Diet on Plasma and Liver Cholesterol In Chicks”.
Circulation,vol. 7, pp. 696-701, (May 1953), O. Pollak “Successful Prevention of Experimental Hypercholestermia and Cholesterol Atherosclerosis in the Rabbit”.
Circulation,vol. 17, pp. 890-899, (May 1958)), J. Farquhar, et al. “Response of Serum Lipids and Lipoproteins of Man to Beta-Sitosterol and Safflower Oil”.
Journal of Lipid Research,vol. 10, pp. 304-315, (1969). S. Grundy, et al. “The Interaction of Cholesterol Absorption and Cholesterol Synthesis in Man”.
Deutsche Medizinische Wochenschrift,vol. 101, pp. 1308-1311, (Sep. 1976), P. Oster, et al. “Sitostenn bei Familiarer Hyperlipoproteinamie Typ II”.
Atherosclerosis,vol. 28, pp. 325-338, (1977), A. Lees, et al. “Plant Sterols as Cholesterol-Lowering Agents: Clinical Trials in Patients with Hypercholesterolemia and Studies of Sterol Balance”.
Münch. Medizinische Wochenschrift,vol. 120, pp. 1575-1578, (1969), W. Schwartzkopff, et al. “Dosiswirksamkeit von β-Sitostenn bei Hypercholesterinämien der Type IIa und IIb”.
The American Journal of Clinical Nutrition,vol. 43, pp. 92-97, (Jan. 1986), R. Tilvis, et al. “Serum Plant Sterols and Their Relation to Cholesterol Absorption”.
American Journal of Epidemiology,vol. 131, No. 1, pp. 20-31, (1990), T. Melttinen, et al. “Serum Plant Sterols and Cholesterol Precursors Reflect Cholesterol Absorption and Synthesis in Volunteers of a Randomly Selected Male Population”.
Scand. Journal. Clin. Lab. Invest.,vol. 48, pp. 715-722, (1988), M. Färkkiä, et al. “Regulation of Plasma Plant Sterol Levels in Patients with Gut Resections”.
Chemical Abstracts,vol. 115, No. 1, (1991), T. Heinemann, et al. Mechanisms of Action of Plant Sterols on Inhibition of Cholesterol Asorption: “Comparison of Sitosterol and Sitostanol”.
Chemical Abstracts,vol. 112, No. 7, (1990), I. Ikeda, et al. “Effects of Sitosterol and Sitostanol and Micellar Solubility of Cholesterol”.
Chemical Abstract,vol. 112, No. 7, (1990), T. Heinemann, et al. “Comparison of Sitosterol and Sitostanol on Inhibition of Intestinal Cholesterol Absorption”.
Chemical Abstracts,vol. 95, No. 13, (1991), I. Ikeda, et al. “Antihypercholesterolemic Activity of β-Sitostanol in Rabbits”.
Chemical Abstract,vol. 88, No. 3, (1978), M. Sugano, et al. “A Comparison of Hypocholesterolemic Activity of β-Sitosterol andβ-Sitostanol in Rats”.
Chemical Abstracts,vol. 71, No. 1, (1969), T. Tsuchiya “Sitosterol Fatty Acid Ester”.
International Search Report, dated Dec. 11, 1991.
International Preliminary Exam Report, dated Aug. 4, 1993.
Copy of Written Opinion from International Preliminary Exam Authority, dated Apr. 12, 1993.
Lipoptotein Metabolism,pp. 112-118, (1976), (Ed. H. Greten Berlin, Heidelberg, New York: Springer-Verlag), S. Grundy, et al. “Effects of Low Dose Phytosterols on Cholesterol Absorption in Man”.
Atherosclerosis,vol. 23, pp. 239-248, (1976,) B. Kudchodkar, et al. “Effects of Plant Sterols on Cholesterol Metabolism in Man”.
Journal of Lipid Research,vol. 29, pp. 1573-1582, (1988), I. Ikeda, et al. “Inhibition of Cholesterol Absorption in Rats by Plant Sterols”.
Journal of Lipid Research,vol. 29, pp. 1583-1591, (1988), I. Ikeda, et al. “Discrimination Between Cholesterol and Sitosterol for Absorption in Rats”.
J. Nutr. Sci. Vitaminol,vol. 35, pp. 361-369, (1989), I. Ikeda, et al. “Effects of Sitosterol and Sitostanol on micellar Solubility of Cholesterol”.
Atherosclerosis,vol. 30, pp. 227-237, (1978), I. Ikeda, et al. Comparison of Absorption and Metabolism of β-Sitosterol and βSitostanol in Rats.
J. Nutr.,vol. 107, pp. 2011-2019, (1977), M. Sugano, et al. A Comparison of Hypochoesteremic Activity of β-Sitosterol and β-Sitostanol in Rats.
Atherosclerosis,vol. 61, pp. 219-223, (1986), T. Heinemann, et al. “Effect of
Miettenen Tatu
Vanhanen Hannu
Wester Ingmar
Arent Fox
Carr Deborah D.
Raisio Benecol Ltd.
LandOfFree
Substance for lowering high cholesterol level in serum and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substance for lowering high cholesterol level in serum and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substance for lowering high cholesterol level in serum and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3686442